396 Overcoming resistance to anti-PD-1 with tumor agnostic NBTXR3: from bench to bed side
Main Authors: | Ping Zhang, Juliette Thariat, Tanguy Seiwert, Maria Angelica Cortez, Jiaxin Niu, Colette Shen, Jessica Frakes, Jared Weiss, Jimmy Caudell, Hu Yun, Sylvie Bonvalot, Zsusanna Papaï, Katherine Jameson, Patricia Said |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Agnostic Validation Test Bench For Efuse Connectivity Verification
by: CHAN , WEI JIAN
Published: (2017) -
1092 Induction of lysosomal membrane permeabilization by radiotherapy-activated NBTXR3 nanoparticles
by: Sébastien Paris, et al.
Published: (2023-11-01) -
Radiotherapy-activated NBTXR3 nanoparticles modulate cancer cell immunogenicity and TCR repertoire
by: Audrey Darmon, et al.
Published: (2022-06-01) -
Radiotherapy-activated NBTXR3 nanoparticles promote ferroptosis through induction of lysosomal membrane permeabilization
by: Jordan Da Silva, et al.
Published: (2024-01-01) -
Imaging Features of Intratumoral Injection of NBTXR3 for Head and Neck Squamous Cell Carcinoma Lymph Node Metastases
by: Daniel Thomas Ginat, et al.
Published: (2022-09-01)